PTPRC and neoplasm: The adoptive transfer of CD45+ erythroblasts into tumor-bearing mice accelerated tumor growth, whereas the in vivo depletion of erythroblasts using anti-CD71 antibodies suppressed tumor progression and restored immune responses to control levels [6].